Hjem › Øsofaguskræft
Øsofaguskræft kliniske forsøg rekrutterer i USA
110 studier for Øsofaguskræft rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Houston, TX36 studier
- Boston, MA23 studier
- New York City, NY22 studier
- Nashville, TN19 studier
- St. Louis, MO17 studier
- Pittsburgh, PA15 studier
- Los Angeles, CA15 studier
- Grand Rapids, MI14 studier
- Baldwin Park, CA14 studier
- Philadelphia, PA13 studier
- San Antonio, TX12 studier
- Dallas, TX11 studier
- Chicago, IL11 studier
- Arlington, VA11 studier
- Rochester, MN11 studier
- San Diego, CA10 studier
- Durham, NC10 studier
- Cleveland, OH10 studier
- Portland, OR10 studier
- Washington, DC9 studier
- Atlanta, GA9 studier
- Denver, CO9 studier
- Detroit, MI9 studier
- Birmingham, AL8 studier
- Orlando, FL8 studier
- Milwaukee, WI8 studier
- Tampa, FL8 studier
- Minneapolis, MN8 studier
- Indianapolis, IN8 studier
- Toledo, OH7 studier
- Aurora, CO7 studier
- Edison, NJ7 studier
- Santa Monica, CA7 studier
- Seattle, WA7 studier
- Mountain View, CA7 studier
- Salt Lake City, UT7 studier
- Baltimore, MD7 studier
- Kansas City, MO7 studier
- Columbus, OH7 studier
- Queens, NY6 studier
Efter delstat
- Alabama8 studier
- Alaska4 studier
- Arizona11 studier
- Arkansas6 studier
- Californien41 studier
- Colorado19 studier
- Connecticut8 studier
- Delaware3 studier
- District of Columbia4 studier
- Florida33 studier
- Georgia11 studier
- Idaho3 studier
- Illinois15 studier
- Indiana12 studier
- Iowa6 studier
- Kansas8 studier
- Kentucky8 studier
- Louisiana5 studier
- Maine3 studier
- Maryland13 studier
- Massachusetts25 studier
- Michigan22 studier
- Minnesota19 studier
- Missouri20 studier
- Montana4 studier
- Nebraska7 studier
- New Jersey9 studier
- New Mexico6 studier
- New York28 studier
- North Carolina16 studier
- North Dakota4 studier
- Ohio22 studier
- Oklahoma8 studier
- Oregon11 studier
- Pennsylvania29 studier
- Rhode Island3 studier
- South Carolina7 studier
- South Dakota4 studier
- Tennessee21 studier
- Texas46 studier
- Utah8 studier
- Virginia16 studier
- Washington11 studier
- West Virginia3 studier
- Wisconsin16 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
RekruttererObservationsstudie
Alder 2 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT00242723Distance-Based Exercise to Preserve Function and Prevent Disability
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07059884A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06465069Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07283939A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT05319730Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06265285Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06760819A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06172478A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07090499A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07814248A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07578571Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07603375Phase 1 Study of PF-08046033 in Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07519655DESTINY-PANTUMOUR04
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 25. sep. 2026 · NCT07124000A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06123338Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06047379Pan-tumor MRD Study
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06605404sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT05332002Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06128551A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07114601A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07213791Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05983432Prehabilitation in High-risk Oncologic Surgery
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT07638410Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07217704Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.